Targeted Rna Sequencing Market Insights:
The market for targeted RNA sequencing has been witnessing substantial growth and is expected to continue expanding in the future. This Targeted RNA Sequencing Market Growth is mainly attributed to advancements in sequencing technologies, rising research endeavours, and the increasing need for personalized medicine and diagnostics. The size of the targeted RNA sequencing market in 2022 is USD 4,554.59 Million, and it is estimated to reach USD 8,684.17 Million by 2030, denoting a CAGR of 8.5% throughout the forecast period.
Targeted RNA sequencing is an advanced method that allows scientists to selectively examine and measure specific RNA molecules. This technology provides a more economical and streamlined approach compared to whole transcriptome sequencing by concentrating on particular RNA targets of interest.
Market definition:
Targeted RNA sequencing, which is also referred to as capture-based RNA sequencing or gene panel sequencing, presents a solution to address these difficulties. By concentrating on a well-defined group of RNA targets, scientists can attain increased sequencing depth and sensitivity, while simultaneously decreasing costs and data complexity.
Market Drivers:
The continuous progress in sequencing technologies has greatly enhanced the effectiveness, precision, and cost efficiency of targeted RNA sequencing. The introduction of high-throughput sequencers and innovative sequencing chemistries allows researchers to acquire substantial volumes of sequencing data within a shorter timeframe and at a lower expense. This facilitates the widespread adoption of targeted RNA sequencing.
The field of genomics research is undergoing rapid growth in RNA sequencing, with a growing number of studies dedicated to gene expression analysis and comprehending disease mechanisms. Targeted RNA sequencing offers researchers a potent instrument to examine specific RNA targets with exceptional precision and sensitivity. The increasing research endeavours in domains such as cancer research, infectious disease studies, and pharmacogenomics propel the demand for targeted RNA sequencing.
Market Restraints:
Targeted RNA sequencing produces significant volumes of data, albeit being less intricate than whole transcriptome sequencing. Analysing and interpreting this data necessitates proficiency in bioinformatics and the availability of robust computational resources. The complexity involved in data analysis can pose challenges for researchers lacking sufficient bioinformatics support.
Targeted RNA sequencing concentrates on a defined group of RNA targets, which may exclude significant RNA molecules that are not part of the selected panel. This limited coverage can lead to the potential loss of valuable information and constrain a comprehensive comprehension of gene expression dynamics
Key Players in the Targeted RNA Sequencing Market
There are several companies actively engaged in the development and commercialization of targeted RNA sequencing technologies and solutions. Here are some key players in the market:
- Roche Holdings
- Illumina Inc.
- Thermo Fisher Scientific
- Agilent Technologies
- Oxford Nanopore Technologies
- QIAGEN
- DNASTAR Inc.
These companies provide a variety of products that cater to the diverse needs of researchers and laboratories. Their offerings include targeted RNA sequencing kits, bioinformatics tools, and customized sequencing services.
Market Segmentation:
The market for targeted RNA sequencing can be divided into different segments based on various factors, such as application, technology, end-user, and region. Here is Analysis of the market segmentation:
By Technology
- Exome Sequencing
- Enrichment Sequencing
- Amplicon Sequencing
By Application
- Biomedical Research
- Plant & Animal Sciences
- Drug Discovery
- Others
By End User
- Academic Research
- Hospitals & Clinics
- Pharma & Biotech Entities
- Others
Regional Analysis:
The targeted RNA sequencing market in North America is propelled by a strong research infrastructure, substantial investments in genomics research, and the presence of major pharmaceutical and biotechnology companies. In European countries, there is a notable emphasis on genomics research and personalized medicine, which contributes to the targeted RNA sequencing demand growth of the targeted RNA sequencing market in the region. Additionally, the Asia Pacific region is experiencing significant growth in targeted RNA sequencing due to increasing research activities, rising investments in genomics research, and a growing focus on personalized medicine.
Frequently Asked Questions:
How does targeted RNA sequencing differ from whole transcriptome sequencing?
Can targeted RNA sequencing be used for clinical applications?
Where can I access targeted RNA sequencing services?
What are the key technologies used in targeted RNA sequencing?
About CBI
Consegic Business Intelligence Pvt Ltd. is the leading research industry that offers contextual and data-centric research services to its customers across the globe. The firm assists its clients to strategize business policies and accomplish sustainable growth in their respective market domains. The industry provides consulting services, syndicated research reports, and customized research reports.
Topnotch research organizations and institutions to comprehend the regional and global commercial status use the data produced by Consegic Business Intelligence Pvt Ltd. Our reports comprise in-depth analytical and statistical analysis on various industries in foremost countries around the globe.
Contact us:
Consegic Business intelligence Pvt Ltd.
Contact no: (US) (505) 715-4344
Email: sales@consegicbusinessintelligence.com